U.S. stock market midday update: Agape ATP down 17.29%, trading volume increased, market sentiment fluctuations attract attention

U.S. Stock Market Midday Update Agape ATP, down 17.29%, with increased trading volume, and no significant news recently. Trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Stocks with High Trading Volume in the Industry McKesson, down 0.60%, with active trading. Based on recent key news: On March 29, MarketBeat analysts reported that although McKesson was rated as "Moderate Buy," top analysts are more optimistic about five other stocks. This rating information may weaken investor confidence in McKesson, thereby affecting its stock price. No other significant news recently. Market capital flows are active, and industry trends need to be monitored. Cencora, up 0.57%. Cencora, up 0.57%. No significant news recently; trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news Cardinal Health, up 1.37%. Based on recent key news: On March 31, Cardinal Health's annualized return over the past five years exceeded the market by 18.56%, with an average annual return of 27.79%. This strong historical performance has boosted investor confidence, driving the stock price up. Source: Benzinga On March 30, Simply Wall St analysts pointed out that Cardinal Health's long-term fundamental data performs well, and although the latest company announcements were not considered, its long-term growth potential is viewed positively by the market. Source: Simply Wall St The pharmaceutical industry has shown robust performance recently, with significant capital inflows. Stocks with High Market Capitalization in the Industry Henry Schein, up 0.08%. Based on recent key news: On March 30, Henry Schein is facing lawsuits related to data breaches in 2023. Although the settlement costs are manageable, these events have led to ongoing increases in costs related to security, insurance, compliance, and customer trust, impacting future profit margins. On March 30, Henry Schein's operating profit margin has decreased from about 7% in 2015-2017 to 5.4% in 2024, and its net profit margin has dropped from a median of 4% to about 3%, indicating a structural decline in profitability. On March 30, analysts rated Henry Schein as a hold, and it was not included in the top five stocks recommended by analysts, with the market taking a wait-and-see attitude towards its future performance. The dental distribution industry is facing competitive pressure and declining profit margins